Boyu Su
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Neurology top 10%
Papers in
- Biomaterials 21
- Nanoparticle-Based Drug Delivery 21
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Chen Jiang (20 shared papers)Tao Sun (18 shared papers)Zhenhao Zhao (11 shared papers)Yifan Luo (10 shared papers)Qinjun Chen (15 shared papers)Zheng Zhou (9 shared papers)Yongchao Chu (10 shared papers)Peixin Liu (7 shared papers)
In The Last Decade
Boyu Su
24 papers receiving 922 citations
Boyu Su's Hit Papers
Peers
Comparison fields: 5 of 65
- Biomaterials 376
- Neurology 86
- Drug Discovery 2
- Biomedical Engineering 171
- Biotechnology 30
Countries citing papers authored by Boyu Su
This map shows the geographic impact of Boyu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyu Su more than expected).
Fields of papers citing papers by Boyu Su
This network shows the impact of papers produced by Boyu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyu Su. The network helps show where Boyu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke Hit paper breakdown → | 2021 | 273 |
| 2 | 2021 | 132 | |
| 3 | 2021 | 126 | |
| 4 | 2022 | 64 | |
| 5 | Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma Hit paper breakdown → | 2025 | 58 |
| 6 | 2023 | 51 | |
| 7 | 2022 | 41 | |
| 8 | 2021 | 27 | |
| 9 | 2022 | 26 | |
| 10 | 2025 | 25 | |
| 11 | 2023 | 24 | |
| 12 | 2021 | 20 | |
| 13 | 2024 | 18 | |
| 14 | 2023 | 13 | |
| 15 | 2024 | 9 | |
| 16 | 2023 | 6 | |
| 17 | 2025 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Boyu Su
Boyu Su is a scholar working on Biomaterials, Pharmaceutical Science, Genetics, Biomedical Engineering and Oncology, having authored 26 papers that have together received 935 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), Nanoplatforms for cancer theranostics (4 papers), Advanced Drug Delivery Systems (3 papers), RNA Interference and Gene Delivery (2 papers), Glioma Diagnosis and Treatment (2 papers), Extracellular vesicles in disease (2 papers), Epigenetics and DNA Methylation (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Biomaterials (376 citations), Neurology (86 citations), Drug Discovery (2 citations), Biomedical Engineering (171 citations) and Biotechnology (30 citations). Boyu Su has collaborated with scholars based in China, Hong Kong and Iran. Frequent co-authors include Chen Jiang, Tao Sun, Zhenhao Zhao, Yifan Luo, Qinjun Chen, Zheng Zhou, Yongchao Chu, Peixin Liu, Hongyi Chen and Haoyu You. Their work appears in journals such as Advanced Materials, ACS Nano, Advanced Science, Small and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.